P/E ratio for Mettler-Toledo (MTD)
P/E ratio as of April 2024 (TTM): 29.7
According to Mettler-Toledo 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.7397. At the end of 2022 the company had a P/E ratio of 37.2.
P/E ratio history for Mettler-Toledo from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 37.2 | -27.02% |
| 2021 | 51.0 | 13.09% |
| 2020 | 45.1 | 30.03% |
| 2019 | 34.7 | 24.81% |
| 2018 | 27.8 | -34.44% |
| 2017 | 42.4 | 47.2% |
| 2016 | 28.8 | 8.4% |
| 2015 | 26.6 | 3.26% |
| 2014 | 25.7 | 8.46% |
| 2013 | 23.7 | 15.32% |
| 2012 | 20.6 | 17.78% |
| 2011 | 17.5 | -19.4% |
| 2010 | 21.7 | 5.64% |
| 2009 | 20.5 | 80.42% |
| 2008 | 11.4 | -51.76% |
| 2007 | 23.6 | 17.73% |
| 2006 | 20.0 | -6.82% |
| 2005 | 21.5 | 2.56% |
| 2004 | 20.9 | 6.18% |
| 2003 | 19.7 | 39.66% |
| 2002 | 14.1 | -51.24% |
| 2001 | 29.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 35.3 | 18.70% | 🇺🇸 USA |
 Waters Corporation WAT | 25.8 | -13.14% | 🇺🇸 USA |
 Xylem XYL | 51.7 | 73.81% | 🇺🇸 USA |
 Danaher DHR | 29.5 | -0.90% | 🇺🇸 USA |
 PerkinElmer
PKI | 15.0 | -49.67% | 🇺🇸 USA |
 Bruker BRKR | 36.2 | 21.73% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -49.1 | -265.20% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.